Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Minimum important difference between patients with rheumatoid arthritis: the patient's perspective.
Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Wells GA, et al. Among authors: kraag gr. J Rheumatol. 1993 Mar;20(3):557-60. J Rheumatol. 1993. PMID: 8478873
Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?
Edworthy S, Zummer M, Garner S, Boire G, Leclercq S, Bykerk V, Kraag G, Markland J, Thomas D, Thomson J, Henderson J. Edworthy S, et al. J Rheumatol. 2008 Aug;35(8):1506-12. Epub 2008 Jun 15. J Rheumatol. 2008. PMID: 18597407
The NSAID dilemma--too many or too few?
Kraag GR. Kraag GR. J Rheumatol. 1982 Sep-Oct;9(5):655-7. J Rheumatol. 1982. PMID: 6757422 Clinical Trial. No abstract available.
Pharmaceutical marketing practices: a victim's perspective.
Kraag GR. Kraag GR. J Rheumatol. 1986 Feb;13(1):224. J Rheumatol. 1986. PMID: 3701736 No abstract available.
The effect of low dose methotrexate on bone density.
Cranney AB, McKendry RJ, Wells GA, Ooi DS, Kanigsberg ND, Kraag GR, Smith CD. Cranney AB, et al. Among authors: kraag gr. J Rheumatol. 2001 Nov;28(11):2395-9. J Rheumatol. 2001. PMID: 11708409 Clinical Trial.
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF, Helve T, Hannonen P, Leirisalo-Repo M, Gilboe IM, Nissilä M, Keystone EC, Kraag GR, Bjørneboe O, Chalmers A, Dovland H, Mueller E, Richard F, Whatmough I, Schmidt AG, Kovarik JM. Anderson IF, et al. Among authors: kraag gr. J Rheumatol. 1999 Mar;26(3):556-62. J Rheumatol. 1999. PMID: 10090162 Clinical Trial.
Impact of patient with patient interaction on perceived rheumatoid arthritis overall disease status.
Baker PR, Groh JD, Kraag GR, Tugwell P, Wells GA, Boisvert D. Baker PR, et al. Among authors: kraag gr. Scand J Rheumatol. 1996;25(4):207-12. doi: 10.3109/03009749609069989. Scand J Rheumatol. 1996. PMID: 8792797
A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
Bellamy N, Bensen WG, Beaulieu A, Siminovitch KA, Kraag GR, Lussier A, Ahmad S, Khanna VN, Davis P, Bell MJ, et al. Bellamy N, et al. Among authors: kraag gr. J Rheumatol. 1995 May;22(5):915-20. J Rheumatol. 1995. PMID: 8587082 Clinical Trial.
A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.
Bellamy N, Buchanan WW, Chalmers A, Ford PM, Kean WF, Kraag GR, Gerecz-Simon E, Campbell J. Bellamy N, et al. Among authors: kraag gr. J Rheumatol. 1993 Jun;20(6):999-1004. J Rheumatol. 1993. PMID: 8350339 Clinical Trial.
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index.
Barr S, Bellamy N, Buchanan WW, Chalmers A, Ford PM, Kean WF, Kraag GR, Gerecz-Simon E, Campbell J. Barr S, et al. Among authors: kraag gr. J Rheumatol. 1994 Nov;21(11):2106-12. J Rheumatol. 1994. PMID: 7869318 Clinical Trial.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback